DLL1 and bacterial infectious disease: Therefore, the aims of this secondary analysis are to evaluate the performance of DLL1 to diagnose bacterial infection as well as to predict a complicated clinical course of patients following liver transplantation compared to standard biomarkers such as PCT or CRP.